JAC Advance Access originally published online on April 14, 2006
Journal of Antimicrobial Chemotherapy 2006 57(6):1077-1082; doi:10.1093/jac/dkl142
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
High prevalence of type b ß-lactamase-non-producing ampicillin-resistant Haemophilus influenzae in meningitis: the situation in Japan where Hib vaccine has not been introduced
1 Laboratory of Infectious Agents Surveillance, Kitasato Institute for Life Sciences, Kitasato University 5-9-1, Shirokane, Minato-ku, Tokyo, Japan 2 National Hospital Organization Tokyo Medical Center Tokyo, Japan 3 Department of Infectious Disease, Kitasato University School of Medicine Kanagawa, Japan
Received 9 December 2005; returned 23 December 2005; revised 13 March 2006; accepted 20 March 2006
*Corresponding author. Tel: +81-3-5791-6385; Fax: +81-3-5791-6386; E-mail: ubukatak{at}lisci.kitasato-u.ac.jp
Objectives: To study yearly changes in resistance and to identify ftsI mutations in ß-lactamase-non-producing ampicillin-resistant (BLNAR) and TEM-1 ß-lactamase-producing amoxicillin/clavulanic acid-resistant (BLPACR) isolates of Haemophilus influenzae from patients with meningitis.
Methods: Between January 2000 and December 2004, we received 621 isolates of H. influenzae from 285 member institutions of the Nationwide Surveillance Study Group for Bacterial Meningitis. All isolates were analysed by PCR to identify resistance genes and tested for susceptibility to ß-lactams. The ftsI gene was sequenced in all BLNAR and BLPACR isolates.
Results: All but four isolates were of serotype b. The isolates could be divided into six classes, namely ß-lactamase-non-producing ampicillin-susceptible (25.0%), TEM-1 ß-lactamase-producing ampicillin-resistant (11.0%), ß-lactamase-non-producing low-level ampicillin-resistant with N526K or R517H substitution in the ftsI gene (30.4%), BLNAR with an S385T substitution together with either N526K or R517H substitution in ftsI (22.2%), BLPACR-I with either a N526K or R517H substitution in ftsI (9.5%) and BLPACR-II with an S385T substitution together with either a N526K or R517H substitution in ftsI (1.9%). The prevalence of BLNAR has increased rapidly, from 5.8% in 2000 to 34.5% in 2004. All BLNAR and BLPACR-II strains were classified into nine subgroups on the basis of substitution patterns in the ftsI gene. The MICs of cephalosporin antibiotics for H. influenzae transformants into which the ftsI genes from BLNAR strains of each of the nine subgroups were introduced increased to varying degrees depending on the mutations.
Conclusions: The results suggest that introduction of H. influenzae type b (Hib) vaccination into infants and children is necessary for the prevention of severe Hib infections in Japan.
Keywords: H. influenzae , BLNAR , PCR
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Hirakata, K. Ohmori, M. Mikuriya, T. Saika, K. Matsuzaki, M. Hasegawa, M. Hatta, N. Yamamoto, H. Kunishima, H. Yano, et al. Antimicrobial Activities of Piperacillin-Tazobactam against Haemophilus influenzae Isolates, Including {beta}-Lactamase-Negative Ampicillin-Resistant and {beta}-Lactamase-Positive Amoxicillin- Clavulanate-Resistant Isolates, and Mutations in Their Quinolone Resistance-Determining Regions Antimicrob. Agents Chemother., October 1, 2009; 53(10): 4225 - 4230. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Garcia-Cobos, J. Campos, F. Roman, C. Carrera, M. Perez-Vazquez, B. Aracil, and J. Oteo Low {beta}-Lactamase-Negative Ampicillin-Resistant Haemophilus influenzae Strains Are Best Detected by Testing Amoxicillin Susceptibility by the Broth Microdilution Method Antimicrob. Agents Chemother., July 1, 2008; 52(7): 2407 - 2414. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Garcia-Cobos, J. Campos, E. Lazaro, F. Roman, E. Cercenado, C. Garcia-Rey, M. Perez-Vazquez, J. Oteo, and F. de Abajo Ampicillin-Resistant Non-{beta}-Lactamase-Producing Haemophilus influenzae in Spain: Recent Emergence of Clonal Isolates with Increased Resistance to Cefotaxime and Cefixime Antimicrob. Agents Chemother., July 1, 2007; 51(7): 2564 - 2573. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Tristram, M. R. Jacobs, and P. C. Appelbaum Antimicrobial Resistance in Haemophilus influenzae Clin. Microbiol. Rev., April 1, 2007; 20(2): 368 - 389. [Abstract] [Full Text] [PDF]
|
|